COMMUNIQUÉS West-GlobeNewswire

Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency
02/01/2018
SEATTLE, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (NASDAQ: CASC ), a clinical-stage biopharmaceutical company, today announced that it received a product-specific pediatric waiver from the European [...]
Sarepta Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference
02/01/2018
CAMBRIDGE, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to [...]
BriaCell To Attend Biotech Showcase™ 2018
02/01/2018
BERKELEY, Calif. and VANCOUVER, British Columbia, Jan. 02, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell") (TSX-V: BCT ) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a [...]
Radius Health Welcomes Elhan Webb as Head of Investor Relations and External Communications
02/01/2018
WALTHAM, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS ) announced today that Elhan Webb has joined the Company as Head of Investor Relations and External [...]
Peregrine Pharmaceuticals to Present at Biotech Showcase 2018
02/01/2018
TUSTIN, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM ) (NASDAQ: PPHMP ), a company committed to improving patient lives by manufacturing and delivering high quality biologics, [...]
Selecta Biosciences Announces FDA Acceptance of Investigational New Drug Application for LMB-100 and SVP-Rapamycin Combination Therapy
02/01/2018
WATERTOWN, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB ), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by avoiding [...]
Achaogen Announces FDA Acceptance of New Drug Application with Priority Review for Plazomicin for Treatment of Complicated Urinary Tract Infections and Bloodstream Infections
02/01/2018
-- Investigational drug has potential to treat certain MDR gram-negative pathogens, including carbapenem-resistant Enterobacteriaceae (CRE) -- -- FDA sets action date of June 25, 2018 -- SOUTH SAN FRANCISCO, Calif., Jan [...]
Achaogen Announces Positive Top-Line Results from First Clinical Trial of Orally-Administered Antibacterial Candidate C-Scape
02/01/2018
-- C-Scape was well tolerated across all doses studied in Phase 1 trial, with no drug-drug interaction between the previously approved compounds when dosed in combination -- -- C-Scape is a combination of ceftibuten and [...]
BIOLIFE4D Names Dr. Ravi Birla as its Chief Science Officer
02/01/2018
CHICAGO, Jan. 02, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D , a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has named Dr. Ravi Birla as its Chief [...]
Selecta Biosciences Announces CEO’s Intent to Retire and Transition Plan
02/01/2018
Dr. Werner Cautreels Plans Retirement at the End of 2018 Dr. Omid Farokhzad Appointed Chairman of the Board WATERTOWN, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB ), a clinical-stage [...]
Inovio Enters License and Collaboration Agreement with ApolloBio To Develop and Commercialize VGX-3100 in Greater China
02/01/2018
PLYMOUTH MEETING, Pa., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) today announced that it entered an amended agreement providing ApolloBio Corporation (NEEQ:430187) with the exclusive [...]
PositiveID Corporation Discusses 2017 Accomplishments in New Interview with CEOLIVE.TV
02/01/2018
DELRAY BEACH, Fla., Jan. 02, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (the “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, announced today that its Chairman and CEO, William J [...]
Avenue Therapeutics Announces Dosing of First Patient in Phase 3 Safety Trial of Intravenous Tramadol for the Management of Postoperative Pain
02/01/2018
NEW YORK, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI ) (“Avenue”), a company focused on the development and commercialization of intravenous (IV) tramadol, today announced that it has [...]
WishBone Medical, Inc. Releases Broken Screw Removal and K-Wire Systems
02/01/2018
WARSAW, Ind., Jan. 02, 2018 (GLOBE NEWSWIRE) -- WishBone Medical, Inc., a new global pediatric orthopedic company, has announced the official launch of the single-use, sterile packed Broken Screw Removal and K-Wire [...]
Nuvus Blockchain Building the New Global Exchange Platform for Medical Cannabis Industry with Nuvus Protocol is Raising $100M Through its Upcoming ICO & Token Sale & is Currently Accepting Whitelist Registration
02/01/2018
Saint Petersburg, FL, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Nuvus Blockchain ( https://www.nuvus.io ), a Nuvus Corp company, formed to build the New Global Exchange Platform with big data and supply chain verification [...]
Golden Leaf Announces Closing of Acquisition of Medical Marijuana Group Consulting Ltd.
02/01/2018
TORONTO, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company built around recognized brands, is pleased to announce that [...]
AnaptysBio Announces Presentation at the J.P. Morgan 36th Annual Healthcare Conference
02/01/2018
SAN DIEGO, Jan. 02, 2018 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB ), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation [...]
Transactions in relation to share buyback program
02/01/2018
Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
ContraVir Pharmaceuticals to Present at Biotech Showcase 2018
02/01/2018
EDISON, N.J., Jan. 02, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced [...]

Pages